Article info
Is it in a neonate's best interest to enter a randomised controlled trial?
Citation
Is it in a neonate's best interest to enter a randomised controlled trial?
Publication history
- First published April 1, 2001.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2001 by the Journal of Medical Ethics
Other content recommended for you
- Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE)
- Aspirin versus metformin in pregnancies at high risk of preterm pre-eclampsia in China (AVERT): protocol for a multicentre, double-blind, 3-arm randomised controlled trial
- Interventions to prevent spontaneous preterm birth in women with singleton pregnancy who are at high risk: systematic review and network meta-analysis
- What are the indications for using probiotics in children?
- Theophylline and aminophylline for prevention of acute kidney injury in neonates and children: a systematic review
- Corticosteroids to safely reduce neonatal respiratory morbidity after late preterm and term planned caesarean section birth? A randomised placebo-controlled feasibility study
- Efficacy of sweet solutions for analgesia in infants between 1 and 12 months of age: a systematic review
- Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence
- A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years
- Should desperate volunteers be included in randomised controlled trials?